Emphysema drug approved.Emphysema emphysema (ĕmfĭsē`mə), pathological or physiological enlargement or overdistention of the air sacs of the lungs. A major cause of pulmonary insufficiency in chronic cigarette smokers, emphysema is a progressive disease that commonly drug approved The Food and Drug Administration this week approved the sale of a purified human protein that can slow the progression of emphysema in patients who fail to produce enough of a critical lung-protecting protein. Up to 40,000 people in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. have a genetic deficiency of the protein, alpha-1 proteinase proteinase /pro·tein·ase/ (pro´ten-as?) endopeptidase. pro·tein·ase n. A protease that begins the hydrolytic breakdown of proteins usually by splitting them into polypeptide chains. inhibitor, also known as alpha-1 antitrypsin (SN: 5/2/87, p.277). Of these, perhaps 2,000 suffer noticeable lung damage and would be considered candidates for treatment with the newly approved drug In the United States, the FDA approves drugs. Before a drug can be prescribed, it must undergo an extensive FDA approval process. This process involves first testing the drug on animals or in medical labs. . The protein will not help the vast majority of emphysema patients who have developed the disease from environmental factors such as cigarette smoking. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion